4218
NICHIBAN CO., LTD
ニチバン株式会社Nichiban Co., Ltd. develops, manufactures, and sells medical products and tapes in Taiwan, Asia, Europe, and internationally. The company offers medical products, including surgical tapes, wound care dressing tapes, post-operative care tapes, cornea protection tapes, and hemostatic and first-aid bandages; and sports tapes, underwraps, scissors, and bags. It also provides navel compression pack, which is used for umbilical hernia compression treatment in infants. In addition, the company offers industrial tapes for use in packaging, carton boxes, agriculture, vehicles, construction, home appliances and electronic materials, and machinery applications, as well as adhesive tapes; cloth tapes; bag sealing machines; washi masking tapes; and sealing machines. Further, the company provides stationery and office products comprising cellulose adhesive tapes, dispensers, double sided tapes, adhesive transfer tapes, book binding tapes, and others. Nichiban Co., Ltd. was founded in 1918 and is headquartered in Tokyo, Japan.
Price
¥1,825
Market Cap
¥37.2B
Ent. Value
¥24.5B
Net Cash
¥12.7B
Shares Out.
20.4M
P / E
19.0×
EV / EBIT
9.5×
P / Book
0.86×
P / NCAV
2.42×
Div. Yield
1.92%
Financials
| Metric |
FY 2024
EDINET ↗ |
FY 2023
EDINET ↗ |
FY 2022
EDINET ↗ |
FY 2021
EDINET ↗ |
|---|---|---|---|---|
| Net Sales | ¥49.5B | ¥46.9B | ¥45.6B | ¥43.1B |
| Cost of Sales | ¥34.6B | ¥33.0B | ¥32.6B | ¥29.6B |
| Gross Profit | ¥14.9B | ¥13.9B | ¥13.0B | ¥13.5B |
| SG&A | ¥12.3B | ¥11.8B | ¥11.4B | ¥11.0B |
| Operating Income | ¥2.6B | ¥2.1B | ¥1.6B | ¥2.5B |
| Non-Operating Income | ¥339M | ¥303M | ¥284M | ¥236M |
| Dividend Income | ¥33M | ¥24M | ¥23M | ¥22M |
| Interest Income | ¥18M | ¥9M | ¥3M | ¥2M |
| Non-Operating Expenses | ¥244M | ¥175M | ¥145M | ¥124M |
| Interest Expense | ¥39M | ¥37M | ¥37M | ¥37M |
| Ordinary Income | ¥2.7B | ¥2.2B | ¥1.7B | ¥2.6B |
| Pre-tax Income | ¥2.6B | ¥2.3B | ¥3.4B | ¥2.6B |
| Income Taxes | ¥668M | ¥445M | ¥1.1B | ¥751M |
| Current Tax | ¥848M | ¥459M | ¥971M | ¥836M |
| Deferred Tax | ¥-179M | ¥-13M | ¥88M | ¥-84M |
| Net Income (owners) | ¥2.0B | ¥1.8B | ¥2.4B | ¥1.8B |
| Comprehensive Income | ¥2.2B | ¥2.3B | ¥2.5B | ¥1.5B |
| EBITDA | ¥5.7B | ¥4.9B | ¥4.4B | ¥5.0B |
| EPS | ¥96.26 | ¥89.00 | ¥114.67 | ¥87.34 |
| Shares Outstanding | 20.4M | 20.4M | 20.6M | 20.7M |
| Shares Issued (total) | 20.7M | 20.7M | 20.7M | 20.7M |
| Treasury Shares | 0.4M | 0.4M | 0.1M | 0.0M |